AI-Driven Drug Design and Solid-State Engineering
From Molecular Affinity to Manufacturable Stability
Engineering Solutions for Clinical-Stage Development
Transforming Drug Discovery with AI
Agilgen is a next-generation biotechnology company transforming drug discovery through artificial intelligence.
We integrate AI-guided molecular design with solid-state engineering to strengthen both binding performance and manufacturability robustness across development milestones.
Our approach bridges discovery optimization and CMC-critical stability evaluation, enabling more confident development decisions prior to scale-up, tech transfer, and regulatory submission.
Two Core Services
Small Molecule Drug Design
AI-assisted molecular design, docking optimization, ADME/Tox prediction, and lead refinement.
Solid-State Engineering
We apply solid-state engineering to strengthen stability, enhance manufacturability, and support CMC-critical decisions for clinical-stage small molecules.
Two Core Services
Small Molecule Drug Design
AI-assisted molecular design, docking optimization, ADME/Tox prediction, and lead refinement.
Explore AI Drug Design →
Solid-State Engineering
We apply solid-state engineering to strengthen stability, enhance manufacturability, and support CMC-critical decisions for clinical-stage small molecules.
Explore Solid Form Engineering →What our clients are saying
Discover innovative digital solutions with Agilgen, advancing technology services for a sustainable future in biotechnology.
Get in Touch
Questions or Comments? We know that our clients have unique needs. Send us a message, and we will get back to you soon.
⚑ 3813 Huron Avenue, Culver City, CA, USA
⏰ Mon–Fri 09:00 am – 05:00 pm
Sat – Sun Closed